Valuation Exelixis, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 30/09/2026			5-day change	1st Jan Change
50.33 ^CHF	+4.05%		+8.00%	-

09-15	Exelixis, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 11:30 AM
09-11	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Inflation Data Release	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,784	5,174	7,460	9,510	11,799	14,473	-	-
Change	-	-10.54%	44.19%	27.47%	24.07%	22.66%	-	-
Enterprise Value (EV) ¹	4,317	3,865	6,465	8,399	10,740	13,728	12,850	11,726
Change	-	-10.45%	67.25%	29.91%	27.88%	27.82%	-6.4%	-8.75%
P/E	25.4x	28.6x	36.9x	18.9x	15.8x	18x	14.9x	11.4x
PBR	2.64x	2.09x	3.21x	4.18x	5.32x	5.56x	4.08x	3.03x
PEG	-	-1.3x	2.3x	0x	0.3x	1.1x	0.7x	0.4x
Capitalization / Revenue	4.03x	3.21x	4.08x	4.39x	5.09x	5.67x	4.98x	4.37x
EV / Revenue	3.01x	2.4x	3.53x	3.87x	4.63x	5.37x	4.42x	3.54x
EV / EBITDA	14.4x	17.4x	32.9x	13.3x	11.9x	12.6x	10.2x	7.35x
EV / EBIT	15.1x	19.2x	37.8x	13.9x	12.3x	13.3x	10.1x	7.46x
EV / FCF	12.8x	17.2x	22.1x	12.5x	12.3x	16.6x	15.8x	8.43x
FCF Yield	7.8%	5.8%	4.53%	8%	8.15%	6.02%	6.32%	11.9%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.72	0.56	0.65	1.76	2.78	3.238	3.914	5.119
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,435	1,611	1,830	2,169	2,320	2,555	2,906	3,315
EBITDA ¹	300.3	222.4	196.6	633.4	901.2	1,093	1,261	1,595
EBIT ¹	286.7	201.5	170.9	604.6	872.2	1,032	1,278	1,572
Net income ¹	231.1	182.3	207.8	521.3	782.6	820.7	1,012	1,248
Net Debt ¹	-1,467	-1,308	-995.3	-1,111	-1,059	-744.5	-1,623	-2,747
Reference price ²	18.28	16.04	23.99	33.30	43.83	58.41	58.41	58.41
Nbr of stocks (in thousands)	316,397	322,561	310,974	285,579	269,203	247,782	-	-
Announcement Date	2/17/22 A	2/7/23 A	2/6/24 A	2/11/25 A	2/10/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	21.73x	7.77x	15.61x	1.37%	74.46B
ARGENX SE	31.25x	9.01x	28.06x	0.04%	60.14B
LONZA GROUP AG	33.64x	6.03x	18.07x	0.97%	48.15B
IQVIA HOLDINGS INC.	34.63x	3.34x	14.4x	-.--%	44.25B
REVOLUTION MEDICINES, INC.	-21.16x	229.18x	-22.81x	-.--%	43.99B
BEONE MEDICINES AG	47.94x	5.54x	30.43x	-.--%	41.61B
CELLTRION, INC.	26.89x	7.76x	19.96x	0.42%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	33.91x	7.26x	18.84x	-.--%	29.31B
INSMED INCORPORATED	-70.02x	13.44x	-68.51x	-.--%	24.93B
Average	15.42x	32.15x	6.01x	0.31%	44.09B
Weighted average by Cap.	19.58x	31.88x	10.24x	0.41%